Loading...
http://jcps.bjmu.edu.cn

Table of Content

    02 October 2025, Volume 34 Issue 9
    Review
    Flavonoids in non-alcoholic fatty liver disease: classification, therapeutic potential, and underlying mechanisms
    Xinyu Wang, Shicheng Li, Mingjing Luo, Dan Li, Chuyu Wang, Xiaoli He, Guang Hu
    2025, 34(9):  801-820.  DOI: 10.5246/jcps.2025.09.059
    Asbtract ( 3 )   HTML ( 2)   PDF (1622KB) ( 2 )  
    Figures and Tables | References | Related Articles | Metrics

    Non-alcoholic fatty liver disease (NAFLD) has emerged as a predominant contributor to chronic liver disorders and hepatocellular carcinoma, representing a significant global health burden. Mounting evidence has implicated obesity, metabolic syndrome, oxidative stress, and insulin resistance (IR) as central drivers of NAFLD pathogenesis. Despite the absence of approved pharmacological therapies or clearly defined molecular targets, flavonoids have garnered increasing attention for their therapeutic potential. As key bioactive molecules, flavonoids may modulate critical gene networks implicated in the progression of NAFLD. In addition to mitigating lipid accumulation induced by IR, these compounds exert multifaceted regulatory effects by modulating proteasome activity, intracellular signaling cascades, gene transcription, and inflammatory processes that contribute to hepatic lipid dysregulation.

    Original articles
    Stability of aluminum hydroxide nanoparticle adjuvants during room temperature storage
    Xifei Yang, Feiwei Zhang
    2025, 34(9):  821-830.  DOI: 10.5246/jcps.2025.09.060
    Asbtract ( 3 )   HTML ( 1)   PDF (2102KB) ( 4 )  
    Figures and Tables | References | Related Articles | Metrics

    Aluminum hydroxide adjuvant exhibits a poorly crystalline boehmite (PCB) structure, which demonstrates instability during prolonged storage. In the present study, we systematically investigated the quality alterations of the adjuvant stored at room temperature by analyzing its crystal structure, particle size distribution, electron microscopic characteristics, pH, isoelectric point (pI), and adsorption capacity. These assessments aimed to ensure the effectiveness and safety of vaccine production. Three batches of adjuvants were stored at room temperature for 15 months, and their changes were monitored using X-ray diffraction patterns, transmission electron microscopy (TEM), pH measurements, pI determination, and adsorption capacity analysis. X-ray diffraction revealed that the crystalline phases of aluminum hydroxide initially exhibited a PCB structure, which became progressively more ordered during storage. Notably, after 12 months, a new diffraction peak emerged at 18.2° 2θ, with its intensity increasing over time. This corresponded to the formation of highly crystalline gibbsite and bayerite, which compromised the stability of the adjuvant. Furthermore, the pH and pI values decreased during storage, reflecting a decline in the chemical stability of the adjuvant. Comprising nanoparticles with a mean diameter of 130 nm, the adjuvant maintained a high surface area and excellent adsorption capacity. The adsorption rate at 8 mg BSA/mg Al3+ consistently exceeded 97%, with no statistically significant differences observed between the adsorption capacities at 1 and 15 months (P > 0.05). This indicated that the nanoparticle aluminum hydroxide adjuvant sustained high adsorption efficiency throughout the storage period, underscoring its reliability as a vaccine adsorbent. However, in the later stages of storage, the emergence of highly crystalline gibbsite and bayerite, coupled with declines in pH and pI, negatively impacted the adjuvant’s stability. Based on these findings, we recommended that aluminum hydroxide adjuvants should not be stored at room temperature for longer than 12 months to preserve their quality and efficacy.

    Bioinformatics-based identification of autophagy-related key genes in osteoarthritis and therapeutic potential analysis of Eucommin A
    Yage Zhang, Zining Peng, Yuwan Zhou, Jinfang Zhang
    2025, 34(9):  831-849.  DOI: 10.5246/jcps.2025.09.061
    Asbtract ( 5 )   HTML ( 2)   PDF (5000KB) ( 4 )  
    Figures and Tables | References | Related Articles | Metrics

    This study aimed to investigate the role of autophagy-related genes in osteoarthritis (OA) and evaluate the therapeutic potential of Eucommin A, a key lignan component derived from Eucommia ulmoides. Gene expression profiles from OA patients and healthy controls were retrieved from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were identified and intersected with autophagy-related genes from the Human Autophagy Database to pinpoint OA-specific autophagy candidates. Functional enrichment analyses via GO and KEGG highlighted involvement in nutrient response, apoptosis, and PI3K-Akt/FoxO signaling pathways. Core genes were prioritized using machine learning algorithms combined with protein-protein interaction (PPI) network analysis, followed by diagnostic validation in an independent cohort. Molecular docking and 100-ns molecular dynamics simulations were conducted to assess the binding stability between Eucommin A and the core targets. Interaction mechanisms were characterized using root mean square deviation (RMSD), root mean square fluctuation (RMSF), radius of gyration (Rg), and MM/GBSA binding free energy calculations. Among 2436 DEGs, 56 were autophagy-related and significantly enriched in key biological processes. Machine learning identified EGFR, MAPK3, and MAPK8 as hub genes, with EGFR and MAPK8 exhibiting significant diagnostic value (AUC > 0.5). Eucommin A demonstrated strong binding affinity to EGFR and MAPK8 via hydrogen bonding and hydrophobic interactions. Molecular dynamics simulations confirmed stable ligand-target complexes and favorable binding free energy profiles. These findings suggested EGFR and MAPK8 as diagnostic biomarkers for OA-related autophagy. Moreover, Eucommin A exerted multi-target therapeutic effects by stabilizing these autophagy-related proteins, proposing a novel strategy for OA treatment through modulation of autophagy.

    Impact of Huanglian Jiedu decoction on myocardial mitochondrial autophagy in spontaneously hypertensive rats
    Yongmei Li, Yuan Wang, Xiaoming Zhang, Yiwen Gao, Chunhong Xin, Nan Zhang
    2025, 34(9):  850-859.  DOI: 10.5246/jcps.2025.09.062
    Asbtract ( 3 )   HTML ( 2)   PDF (1551KB) ( 4 )  
    Figures and Tables | References | Related Articles | Metrics

    Hypertension is one of the most prevalent cardiovascular diseases, and autophagy is known to play a significant role in the pathogenesis and progression of cardiovascular conditions. This study aimed to evaluate the effects of Huanglian Jiedu decoction (HLJDD) on myocardial mitochondrial autophagy in spontaneously hypertensive rats (SHRs) and to further explore the relationship between autophagy, myocardial remodeling, and injury. The SHRs were randomly assigned to five groups: the model group, the HLJDD low-dose group, the HLJDD medium-dose group, the HLJDD high-dose group, and a positive control group treated with captopril. Additionally, a blank control group was established using Wistar Kyoto (WKY) rats, with 10 rats in each group. The model and blank control groups were administered an equivalent volume of physiological saline via oral gavage, while the treatment groups received their respective doses of HLJDD or captopril by oral gavage. Following the treatments, various parameters were assessed, including blood pressure (systolic, diastolic, and mean arterial pressure), mitochondrial swelling and membrane potential, free ATPase activity, as well as the mRNA and protein levels of autophagy-related factors. The results showed that HLJDD significantly reduced blood pressure (systolic, diastolic, and mean arterial pressure) in SHR rats. Moreover, it enhanced mitochondrial swelling and membrane potential, increased mitochondrial ATPase activity, and decreased the mRNA and protein expression levels of autophagy-related genes (AKT, mTOR, Beclin-1, and LC3-II) in SHRs. The findings of this study suggested that HLJDD could effectively ameliorate myocardial tissue injury in SHRs, and its protective effects on the heart might be attributed to the reduction of autophagy in cardiomyocyte mitochondria. This provided insights into the potential therapeutic use of HLJDD in managing hypertension-induced myocardial injury and remodeling.

    Exploring the mechanism of Toddalia asiatica (L.) Lam. in the treatment of osteoarthritis through bioinformatics and network pharmacology
    Qian Deng, Zining Peng, Danning Mao, Yuanbo Huang, Nian Liu, Weitian Yan, Jiangyun Peng
    2025, 34(9):  860-872.  DOI: 10.5246/jcps.2025.09.063
    Asbtract ( 5 )   HTML ( 2)   PDF (5676KB) ( 4 )  
    Figures and Tables | References | Related Articles | Metrics

    This study employed an integrated approach combining bioinformatics and network pharmacology to elucidate the potential active compounds and mechanisms of action of Toddalia asiatica (L.) Lam. (T. asiatica) in treating osteoarthritis (OA). Initially, the components of T. asiatica were extracted from the literature, and their ADMF properties were assessed using SwissADME. Subsequently, the corresponding targets for the effective components were predicted through the SwissTargetPrediction database. A drug-component-target network was then constructed using Cytoscape, which facilitated the identification of the primary active components based on their degree values within the network. In parallel, differentially expressed genes related to OA were comprehensively analyzed utilizing GEO data. The intersection of the targets from T. asiatica and those associated with OA was determined, followed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses, as well as the construction of a protein-protein interaction (PPI) network through the String platform. The topological network was visualized using Cytoscape, and core genes were identified via the Cytohubba plugin. In total, 54 effective components and 694 corresponding targets of T. asiatica were predicted. Based on the degree values from the drug-component-target network, 22 principal active components were ultimately identified. From the GEO database, 493 OA-related targets were retrieved, revealing 46 shared targets between T. asiatica and OA. The enrichment analysis of these intersecting genes suggested that T. asiatica may exert anti-OA effects through multiple components, targets, and pathways. Notably, the PPI network analysis highlighted MCL1 as a core target. The diagnostic potential of this gene was further evaluated using an external validation set for OA. Additionally, the binding affinity of the 22 main active components of T. asiatica to MCL1 was elucidated through molecular docking studies. This research enhanced our understanding of the pharmacological effects of T. asiatica against OA and its active components, providing valuable insights and evidence for future studies.

    Tacrolimus-associated gastrointestinal ulcers: An observational retrospective study in pharmacovigilance
    Xin Yu, Xin Feng, Zhuoling An, Hui Yang
    2025, 34(9):  873-881.  DOI: 10.5246/jcps.2025.09.064
    Asbtract ( 3 )   HTML ( 2)   PDF (1473KB) ( 4 )  
    Figures and Tables | References | Related Articles | Metrics

    Tacrolimus (Tac) is a cornerstone immunosuppressant in the treatment regimens for organ transplant recipients. However, its extensive clinical use has brought attention to its associated drug safety concerns. Recent case reports highlighting Tac-induced gastrointestinal ulcers have prompted further investigation. In the present study, we analyzed Tac-associated adverse events using data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) to identify potential adverse event signals. Adverse event reports were collected up to the third quarter (Q3) of 2023, revealing 339 cases of Tac-related gastrointestinal ulcers. A disproportionality analysis was conducted utilizing the Bayesian confidence propagation neural network of information component (IC) and reporting odds ratio (ROR) methods. All statistical analyses were performed using R version 3.6.1. The findings demonstrated a significant signal for gastrointestinal ulcers associated with Tac use, with a ROR1 of 1.87 (95% CI: 1.68–2.08) and an IC1 of 0.89 (95% CI: 0.73–1.05) when compared to all other drugs. When compared specifically to cyclosporine, Tac also showed a significant signal (ROR2 = 1.55, 95% CI: 1.28–1.86; IC2 = 0.24, 95% CI: 0.04–0.44). Further analysis identified age, male gender, and European descent as risk factors for mortality outcomes in patients with Tac-associated gastrointestinal ulcers. These findings highlighted the critical need for clinicians to strengthen the monitoring and early detection of gastrointestinal ulcers in patients undergoing Tac therapy. Enhanced vigilance in this regard is essential to optimize the management and care of transplant patients.

    Empirical analysis of factors influencing postdoctoral academic growth in pharmaceutical schools and universities: A case study of Peking University School of Pharmaceutical Sciences
    Xun Wang, Linjie Yang
    2025, 34(9):  882-890.  DOI: 10.5246/jcps.2025.09.065
    Asbtract ( 3 )   HTML ( 2)   PDF (1481KB) ( 4 )  
    Figures and Tables | References | Related Articles | Metrics

    Universities serve as pivotal platforms for cultivating postdoctoral talent, particularly in pharmaceutical sciences. This study provided an empirical assessment of the key determinants influencing research productivity among postdoctoral fellows in this field. We analyzed a cohort of postdoctoral researchers who entered the School of Pharmaceutical Sciences at Peking University between October 2016 and December 2024, gathering comprehensive data on their demographic characteristics and scholarly accomplishments throughout their fellowship. Indicators of postdoctoral success encompassed securing research funding, publishing scholarly articles, and filing patent applications. To identify the principal factors shaping these outcomes, we employed logistic regression analysis. The findings demonstrated that postdoctoral fellows enrolled in incentive programs exhibited markedly higher success rates in acquiring research grants, especially high-tier funding, as well as in publishing both general and high-impact research articles. Conversely, fellows engaged in interdisciplinary research showed significantly reduced success rates in obtaining both general and high-level grants. Additionally, extended fellowship durations were positively correlated with greater likelihoods of publishing high-impact papers and achieving patents. Notably, postdoctoral fellows specializing in Pharmaceutical Analysis had a significantly higher probability of securing prestigious research grants, while those focusing on Pharmaceutics demonstrated a superior capacity for research publication. Regarding intellectual property, fellows mentored by supervisors with overseas experience were substantially more likely to obtain patents, whereas those guided by tenure-track supervisors exhibited lower patent acquisition rates. In light of these insights, we proposed several recommendations for postdoctoral management bodies within pharmaceutical academic institutions. These included refining selection criteria for postdoctoral candidates, amplifying support through incentive mechanisms, enhancing interdisciplinary fellows’ integration into pharmaceutical research paradigms, and optimizing postdoctoral training frameworks to nurture academic excellence and research innovation.

    News
    The research team of Prof. Suwei Dong from Peking University and their collaborators discovered O-glycopeptide participates in the formation of distinct Aβ42 fibril structures and inhibit its pathological toxicity
    State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
    2025, 34(9):  891-891. 
    Asbtract ( 1 )   PDF (1434KB) ( 4 )  
    Related Articles | Metrics
    The research team of Prof. Suwei Dong from Peking University and their collaborators discovered O-glycopeptide participates in the formation of distinct Aβ42 fibril structures and inhibit its pathological toxicity.
    The research team of Prof. Haiyan Xie developed a tumor xenograft system based on bacterial outer membrane vesicles
    State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
    2025, 34(9):  892-893. 
    Asbtract ( 3 )   PDF (1292KB) ( 5 )  
    Related Articles | Metrics
    The research team of Prof. Haiyan Xie developed a tumor xenograft system based on bacterial outer membrane vesicles.
    The research team of Prof. Lei Miao from Peking University has developed an efficient and low-toxic inhalable mRNA LNP for the treatment of chronic lung injury
    State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
    2025, 34(9):  894-894. 
    Asbtract ( 4 )   PDF (1426KB) ( 5 )  
    Related Articles | Metrics
    The research team of Prof. Lei Miao from Peking University has developed an efficient and low-toxic inhalable mRNA LNP for the treatment of chronic lung injury.
    The research teams of Prof. Jingyang Guan and Prof. Hongkui Deng have achieved new results in the field of chemical reprogramming: chemical reprogramming human blood cells to pluripotent stem cells for the first time
    Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center
    2025, 34(9):  895-896. 
    Asbtract ( 2 )   PDF (1405KB) ( 5 )  
    Related Articles | Metrics
    The research teams of Prof. Jingyang Guan and Prof. Hongkui Deng have achieved new results in the field of chemical reprogramming: chemical reprogramming human blood cells to pluripotent stem cells for the first time.